Expertise in
4
conditions

Pierre E. Charles

Paris, FR 
Expertise in
4
conditions
Paris, FR 

Overview

Pierre Charles practices practicing medicine in Paris, France.

Mr. Charles is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Vasculitis, Granulomatosis with Polyangiitis, Acute Interstitial Pneumonia, and Interstitial Lung Disease.

He is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
14 Rue Gaffarel, B.P. 77908-21079, Dijon, 21079, France
Suresnes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
A Randomized Trial of Efficacy and Safety of an Early OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome: a Strategy to Prevent Hospitalization
A Randomized Trial of Efficacy and Safety of an Early OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome: a Strategy to Prevent Hospitalization
Enrollment Status: Withdrawn
Publish Date: April 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

55 Total Publications

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.
Journal: Journal of internal medicine
Published: November 24, 2025

Frequently Asked Questions about Pierre E. Charles

Is Pierre E. Charles a top-rated expert for Vasculitis?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre E. Charles is classified as an Distinguished expert for Vasculitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre E. Charles participate in research or clinical trials?

Yes. Pierre E. Charles has published 55 articles and abstracts on conditions like Vasculitis. You can view a list of Pierre E. Charles's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Charles's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile